Blood Res.  2021 Mar;56(1):44-46. 10.5045/br.2021.2020184.

Emicizumab prophylaxis in a Korean child with severe hemophilia A and high titer inhibitor: a case report

Affiliations
  • 1Department of Pediatrics, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea.
  • 2Department of Pediatrics, Keimyung University School of Medicine, Keimyung University Daegu Dongsan Hospital, Daegu, Korea.

Abstract

No abstract available

Full Text Links
  • BR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error